Mei Meng
Impact in
-
- Natural Compounds in Disease Treatment
-
- Cancer-related molecular mechanisms research
Papers in
-
- Gut microbiota and health 3
- Angiogenesis and VEGF in Cancer 2
- Immunology 13
- Immune Response and Inflammation 5
- Immunotherapy and Immune Responses 4
- Co-authors
- Quansheng Zhou (19 shared papers)Nathan J. Klingensmith (4 shared papers)Craig M. Coopersmith (4 shared papers)Ping Yang (7 shared papers)Zhifei Cao (9 shared papers)Jianchang Chen (1 shared paper)Jing Zhao (1 shared paper)Zhe Zhao (7 shared papers)
- Journals
- Biochemical Pharmacology (4 papers)Frontiers in Pharmacology (4 papers)Cell Death and Differentiation (2 papers)Cell Death and Disease (2 papers)Toxicology and Applied Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Mei Meng
51 papers receiving 847 citations
Peers
Comparison fields: 5 of 86
- Complementary and alternative medicine 75
- Cancer Research 99
- Critical Care and Intensive Care Medicine 30
- Immunology 123
- Molecular Biology 343
Countries citing papers authored by Mei Meng
This map shows the geographic impact of Mei Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Meng more than expected).
Fields of papers citing papers by Mei Meng
This network shows the impact of papers produced by Mei Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Meng. The network helps show where Mei Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Mei Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 111 | |
| 2 | 2014 | 79 | |
| 3 | 2017 | 45 | |
| 4 | 2015 | 37 | |
| 5 | 2016 | 33 | |
| 6 | 2021 | 33 | |
| 7 | 2019 | 29 | |
| 8 | 2020 | 28 | |
| 9 | 2014 | 26 | |
| 10 | 2019 | 24 | |
| 11 | 2021 | 22 | |
| 12 | 2021 | 21 | |
| 13 | 2019 | 21 | |
| 14 | 2012 | 18 | |
| 15 | 2018 | 18 | |
| 16 | 2016 | 18 | |
| 17 | 2020 | 18 | |
| 18 | 2016 | 18 | |
| 19 | 2012 | 18 | |
| 20 | 2021 | 17 |
About Mei Meng
Mei Meng is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 51 papers that have together received 848 indexed citations. Recurring topics across this work include Immune Response and Inflammation (5 papers), Immunotherapy and Immune Responses (4 papers), Gut microbiota and health (3 papers), Natural Compounds in Disease Treatment (3 papers), Cancer Mechanisms and Therapy (3 papers), Cancer, Lipids, and Metabolism (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Complementary and alternative medicine (75 citations), Cancer Research (99 citations), Critical Care and Intensive Care Medicine (30 citations), Immunology (123 citations) and Molecular Biology (343 citations). Mei Meng has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Quansheng Zhou, Nathan J. Klingensmith, Craig M. Coopersmith, Ping Yang, Zhifei Cao, Jianchang Chen, Jing Zhao, Zhe Zhao, Yanyan Pan and Chengyong Qin. Their work appears in journals such as Biochemical Pharmacology, Frontiers in Pharmacology, Cell Death and Differentiation, Cell Death and Disease and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.